Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
Open Access
- 29 May 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 96 (11), 1656-1658
- https://doi.org/10.1038/sj.bjc.6603797
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- ReplyGastroenterology, 2006
- Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor PrognosisGastroenterology, 2006
- Population-based study of the diagnosis and treatment of gastrointestinal stromal tumoursBritish Journal of Surgery, 2006
- Gastrointestinal Stromal Tumors of the Stomach in Children and Young AdultsThe American Journal of Surgical Pathology, 2005
- Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate eraCancer, 2005
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Metastasizing gastric epithelioid leiomyosarcomas (leiomyoblastomas) in young individuals with long-term survivalCancer, 1992